India Pharmas Can Expect Up To 14% Growth This Fiscal Year, Execs Say
This article was originally published in PharmAsia News
India's pharmaceutical industry is forecast to see revenue growth of as much as 14% in the just-begun current fiscal year, reversing a negative impact of recent trade issues and government price controls.
You may also be interested in...
From enforced detention to hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Comments ahead of the vaccine advisory committee ranged from public health groups opposed to emergency use authorizations, to industry requests for guidance on EUA labeling materials.
"One of the issues that COVID-19 has brought out is, how safe is the production of animal-based food products?"